Trial intelligence / Profile preview

Sildenafil for Right Ventricular Contractility in Pediatric Pulmonary Arterial Hypertension

NCT00742014Phase 3Terminated

Sponsor
SickKids
Start
Aug 2008
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by SickKids. Primary endpoint: Increase in endsystolic elastance of the right ventricle from baseline. Started Aug 2008; status: terminated.

02

Drugs

ASP-001
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT00742014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00742014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call